Visby Medical has raised substantial capital across multiple funding rounds, with a total of $386M raised to date. The company is backed by prominent investors including Pitango, Sinai, and Artiman, supporting its mission to revolutionize infectious disease diagnostics with portable, instrument-free PCR solutions.
What Is Visby Medical and What Does It Do?
Visby Medical, founded in 2010 by Adam De la Zerda, is headquartered in San Jose, California. The company develops diagnostic products to detect infectious diseases, offering compact, handheld PCR devices that rapidly test for serious respiratory and sexually transmitted infections without requiring complex instruments.
Visby Medical integrates cutting-edge technology to make diagnostics faster, more accessible, and patient-friendly. Employing 251 people, the company has positioned itself as a leader in portable diagnostics, serving hospitals, clinics, and healthcare providers globally.
How Much Funding Has Visby Medical Raised?
1. Series E
- Amount Raised: $100M
- Date: March 2022
- Lead Investors: Hoopp, Cedars Sinai, ND Capital, Artiman, Pitango, Ping An Voyager Partners, Blue Water Life Science Advisors, Nissim Capital, John Doerr
- Motivation: To scale diagnostic technology production and expand market reach.
2. Series E (Follow-up)
- Amount Raised: $35M
- Date: June 2022
- Lead Investors: Lightrock, John Doerr, Cedars Sinai, ND Capital, Artiman, Pitango, Blue Water Life Science Advisors, J Ventures
- Motivation: To accelerate commercial adoption of portable PCR devices.
3. Series F
- Amount Raised: $55M
- Date: June 2025
- Lead Investors: Catalio Capital Management, Cedars Sinai, ND Capital, Blue Water Life Science Advisors, John Doerr, Pitango
- Motivation: To fund further R&D and scale manufacturing capabilities.
Total Funding Raised: $386 Million
Current Valuation: $1 Billion (as of July 2022)
Latest Funding Date: June 2025
Key Investors
1. Pitango
- Details: Venture capital firm investing across health tech, biotech, and software.
- Investment Focus Areas: Healthcare, diagnostics, life sciences.
- Notable Investments: Visby Medical, Nucleai, DayTwo.
2. Catalio Capital Management
- Details: Growth-stage healthcare investment firm.
- Investment Focus Areas: Biotech, medtech, diagnostics.
- Notable Investments: Verana Health, Visby Medical.
3. Hoopp
- Details: Investment fund focused on high-growth technology and healthcare ventures.
- Investment Focus Areas: Healthcare technology, life sciences.
- Notable Investments: Visby Medical, other medtech startups.
Where Is Visby Medical’s Headquarters?
Visby Medical is headquartered in San Jose, California, a hub for healthcare innovation and biotechnology, enabling access to advanced research, clinical partnerships, and a strong talent pool.
What’s Next for Visby Medical?
Visby Medical aims to expand global adoption of its handheld PCR diagnostics, enhance R&D for new infectious disease tests, and strengthen manufacturing and distribution networks. With a $1B valuation and robust investor support, the company is poised to address urgent diagnostic needs, improve patient outcomes, and solidify its position as a leader in portable, rapid diagnostic solutions.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like Visby Medical. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.
